An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

By O. Kopper, C. J. de Witte, K. Lõhmussaar, J. E. Valle-Inclán, N. Hami, L. Kester, Anjali Vanita Balgobind, J. Korving, Natalie Proost, H. Begthel and 21 more. Nature Medicine, 2019

718 citations recorded by the source corpus.

Subfields: Cancer Research, Oncology, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/3bdc23048c5513ddd1f1cd51ea6b4f5f00707e03

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Guo-li Ming
2. Hongjun Song

In Oncology

1. Guo-li Ming
2. Hongjun Song

Citations in the corpus

• A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity. (2019, background): “Organoids have since been applied to model various cancers, including pancreatic, prostate, liver, breast, bladder, ovarian, and gastrointestinal cancers (Boj et al., 2015; Broutier et al., 2017; Gao et al., 2014; Kopper et al., 2019; Lee et al., 2018; Sachs et al., 2018; Yan et al., 2018).”